OnCoCross Co Ltd
KOSDAQ:382150
Decide a qué precio te sentirías cómodo comprando y te ayudaremos a estar preparado.
|
O
|
OnCoCross Co Ltd
KOSDAQ:382150
|
KR |
|
Eurocommercial Properties NV
F:N4SA
|
NL |
|
K
|
Kohinoor Industries Ltd
KAR:KOIL
|
PK |
|
C
|
Company K Partners Ltd
KOSDAQ:307930
|
KR |
|
A
|
Actions Technology Co Ltd
SSE:688049
|
CN |
|
Symrise AG
F:SY1
|
DE |
|
A
|
Attendo AB (publ)
F:7AT
|
SE |
|
R
|
Reliance Insurance Co Ltd
KAR:RICL
|
PK |
|
D
|
Devon Energy Corp
F:DY6
|
US |
|
S
|
Shilp Gravures Ltd
BSE:513709
|
IN |
|
M
|
Metals Australia Ltd
ASX:MLS
|
AU |
|
Nordic Semiconductor ASA
OTC:NDCVF
|
NO |
|
B
|
BingEx Ltd
NASDAQ:FLX
|
CN |
|
Graph Blockchain Inc
OTC:REGRF
|
CA |
|
O
|
Organic Meat Company Ltd
KAR:TOMCL
|
PK |
|
A
|
Agilyx ASA
XMUN:5NQ
|
NO |
|
Canon Inc
TSE:7751
|
JP |
|
V
|
Velocity Minerals Ltd
F:VMSP
|
CA |
|
Avro India Ltd
BSE:543512
|
IN |
|
O
|
Obzen Inc
KOSDAQ:417860
|
KR |
|
1
|
1CM Inc
OTC:MILFF
|
CA |
|
Alexander Marine Co Ltd
TWSE:8478
|
TW |
|
Q
|
Queen's Road Capital Investment Ltd
TSX:QRC
|
HK |
|
I
|
IDeA Indonesia Akademi Tbk PT
IDX:IDEA
|
ID |
Valor intrínseco
No hay suficientes datos para calcular de forma fiable el valor intrínseco de OnCoCross Co Ltd.
¿Nuestras valoraciones funcionan de verdad? Ver resultados del backtest .
Análisis fundamental
Qué hace OnCoCross
Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-12-18. The firm mainly develops artificial intelligence (AI) new drug development platform based on its original technology which analyzing changes in gene expression data (Transcriptome) due to drug administration or disease occurrence and using AI to match the optimal disease and treatment.
- Sede central
- Corea KR
- Empleados
- 31
- Fecha de salida a bolsa
- 18 dic., 2024
